Try a new search

Format these results:

Searched for:

person:geronr01

in-biosketch:true

Total Results:

322


Safety and Utility of a Novel Nitrous Oxide Delivery System in Cosmetic Surgery: A National Survey of Physician Practices

Wang, Jordan V; Munavalli, Girish S; Pozner, Jason; Geronemus, Roy G
PMID: 34313636
ISSN: 1524-4725
CID: 4949222

Experiences and Perspectives of Patients With Striae: A Survey With Treatment Implications

Wang, Jordan V; Kream, Elizabeth J; Munavalli, Girish S; Geronemus, Roy G
PMID: 34313640
ISSN: 1524-4725
CID: 4949232

Assessment of Treatment Tolerance and Parental Perspective of Outpatient Pulsed-Dye Laser Treatment for Port-Wine Birthmark without General Anesthesia in Infants and Toddlers

Feng, Hao; Materne, Grace; Ghalili, Sabrina; Lederhandler, Margo; Pomerantz, Hyemin; Christman, Mitalee; Bernstein, Leonard J; Geronemus, Roy G
PMID: 33010319
ISSN: 1097-6787
CID: 4626412

Combining cosmetic injectables with low-energy, low-density 1927 nm fractional thulium fiber laser: A 2.5-year examination on the safety of same-day treatments

Wang, Jordan V; Akintilo, Lisa; Geronemus, Roy G
Combining laser treatments with cosmetic injectables can offer synergistic benefit, increased convenience for both patients and physicians, and lessened overall patient downtime. Although paired treatments can be effective, there remain theoretical concerns that this may add new risks. Theoretical risks of combining laser treatment with neurotoxin injections include unintentional spread of the neurotoxin, which may result in eyelid ptosis and muscle weakness. Potential risks with soft-tissue fillers include unexpected loss of filler volume, necrosis, burn, and product migration. This retrospective chart review of single-session, same-day facial treatments using a low-energy, low-density 1927 nm fractional thulium fiber laser and cosmetic injectables found no adverse events related to this combination approach. This is important safety information that can offer reassurance to physicians using this clinical approach.
PMID: 33742533
ISSN: 1473-2165
CID: 4821982

Cost Savings of In-Office Pulsed Dye Laser Treatment of Port-Wine Birthmarks Without General Anesthesia

Wang, Jordan V; Albornoz, Christian A; Geronemus, Roy G
PMID: 33941728
ISSN: 1524-4725
CID: 4866092

Single-Session Treatment With Botulinum Toxin and 755-nm Picosecond Laser With Diffractive Lens Array: A 5-Year Safety Review

Wang, Jordan V; Albornoz, Christian A; Anolik, Robert; Geronemus, Roy G
PMID: 34115677
ISSN: 1524-4725
CID: 4900382

Pairing Facial Fillers With 755-nm Picosecond Laser With Diffractive Lens Array: A 5-Year Safety Evaluation of Single-Session Treatments

Wang, Jordan V; Ugonabo, Nkemjika; Anolik, Robert; Geronemus, Roy G
PMID: 34115685
ISSN: 1524-4725
CID: 4900392

Real-World Experience With Oral Tranexamic Acid and Lasers for Pigmentary Disorders: A 5-Year Safety Review

Wang, Jordan V; Valiga, Alexander; Geronemus, Roy G
PMID: 34115690
ISSN: 1524-4725
CID: 4900402

Cosmetic Consumer Preferences During COVID-19 Pandemic: A New Normal?

Wang, Jordan V; Munavalli, Girish S; Zachary, Christopher B; Geronemus, Roy G
PMID: 33731565
ISSN: 1524-4725
CID: 4817912

Dynamic Optical Coherence Tomography of Cutaneous Blood Vessels in Melasma and Vessel Response to Oral Tranexamic Acid [Case Report]

Pomerantz, Hyemin; Christman, Mitalee P; Bloom, Bradley S; Lederhandler, Margo; Feng, Hao; Holmes, Jon; Geronemus, Roy G
BACKGROUND AND OBJECTIVES/OBJECTIVE:Melasma may be related to aberrant blood vessels, but there has been no report on the utility of dynamic optical coherence tomography (D-OCT) in studying vessel characteristics in melasma. We studied the characteristics of cutaneous blood vessels in melasma and the effects of oral tranexamic acid (TXA) with D-OCT. STUDY DESIGN/MATERIALS AND METHODS/METHODS:Six patients with moderate to severe melasma had a D-OCT scanning of the areas on the face affected by melasma and not affected by it. Three of them had scans within 3 months after starting oral TXA and at a follow-up visit. Blood flow at different depths of the skin and vessel diameter were compared between the melasma and normal skin. For those taking oral TXA, we compared the percent change of blood flow and diameter between the melasma and normal skin. RESULTS:Dermal blood flow and vessel diameter were greater in the melasma skin than in the normal skin. Oral TXA reduced dermal blood flow in both the melasma and normal skin, but the reduction was more dramatic in the lesional melasma skin. CONCLUSIONS:D-OCT findings that (i) dermal blood vessels in melasma are increased in size and flow and (ii) oral TXA reduced the vessel size and flow, providing evidence supporting the relationship between melasma and cutaneous blood vessels. D-OCT may be utilized in measuring response to treatments targeting melasma. Lasers Surg. Med. © 2020 Wiley Periodicals LLC.
PMID: 33161588
ISSN: 1096-9101
CID: 4662962